Zuber M X, Mason J I, Simpson E R, Waterman M R
Department of Biochemistry, University of Texas Health Science Center, Dallas 75235.
Proc Natl Acad Sci U S A. 1988 Feb;85(3):699-703. doi: 10.1073/pnas.85.3.699.
Transfected, nonsteroidogenic COS-1 cells derived from monkey kidney are found to be capable of supporting the initial and rate-limiting step common to all steroidogenic pathways, the side-chain cleavage of cholesterol to produce pregnenolone. Endogenous COS-1 kidney cell renodoxin reductase and renodoxin are able to sustain low levels of this activity catalyzed by bovine cholesterol side-chain cleavage cytochrome P450 (P450scc) whose synthesis is directed by a transfected plasmid containing P450scc cDNA. Double transfection with both P450scc and adrenodoxin plasmids leads to greater pregnenolone production and indicates that adrenodoxin plays a role as a substrate for this reaction or that bovine adrenodoxin serves as a better electron donor than the endogenous iron-sulfur protein renodoxin. Also it is found that both the bovine adrenodoxin and P450scc precursor proteins are proteolytically processed upon their uptake by COS-1 cell mitochondria to forms having the same electrophoretic mobility as mature bovine adrenodoxin and P450scc. Following triple transfection of COS-1 cells with P450scc, adrenodoxin, and 17 alpha-hydroxylase cytochrome P450 plasmids, pregnenolone produced in mitochondria by the side-chain cleavage reaction can be further metabolized in the endoplasmic reticulum to 17 alpha-hydroxypregnenolone and dehydroepiandrosterone. Although this functional steroidogenic pathway can be incorporated into this nonsteroidogenic cell type, it is found to be nonresponsive to cAMP, a potent activator of steroid hormone biosynthesis in adrenal cortex, testis, and ovary. Thus the cellular mechanisms necessary to support both microsomal and mitochondrial steroid hydroxylase activities appear not to be tissue specific, whereas the acute cAMP-dependent regulation of steroidogenesis is not present in transformed kidney (COS-1) cells.
源自猴肾的转染非类固醇生成COS - 1细胞能够支持所有类固醇生成途径共有的初始限速步骤,即胆固醇侧链裂解生成孕烯醇酮。内源性COS - 1肾细胞还原型辅酶Ⅱ - 细胞色素P450还原酶和铁氧化还原蛋白能够维持由牛胆固醇侧链裂解细胞色素P450(P450scc)催化的低水平活性,其合成由含有P450scc cDNA的转染质粒指导。用P450scc和肾上腺皮质铁氧化还原蛋白质粒进行双重转染会导致更多孕烯醇酮的产生,这表明肾上腺皮质铁氧化还原蛋白作为该反应的底物发挥作用,或者牛肾上腺皮质铁氧化还原蛋白作为比内源性铁硫蛋白铁氧化还原蛋白更好的电子供体。此外,还发现牛肾上腺皮质铁氧化还原蛋白和P450scc前体蛋白在被COS - 1细胞线粒体摄取后会被蛋白水解加工成与成熟牛肾上腺皮质铁氧化还原蛋白和P450scc具有相同电泳迁移率的形式。在用P450scc、肾上腺皮质铁氧化还原蛋白和17α - 羟化酶细胞色素P450质粒对COS - 1细胞进行三重转染后,线粒体中由侧链裂解反应产生的孕烯醇酮可在内质网中进一步代谢为17α - 羟孕烯醇酮和脱氢表雄酮。尽管这种功能性类固醇生成途径可以整合到这种非类固醇生成细胞类型中,但发现它对环磷酸腺苷(cAMP)无反应,而cAMP是肾上腺皮质、睾丸和卵巢中类固醇激素生物合成的有效激活剂。因此,支持微粒体和线粒体类固醇羟化酶活性所需的细胞机制似乎不是组织特异性的,而类固醇生成的急性cAMP依赖性调节在转化的肾(COS - 1)细胞中不存在。